Briefs

JPMorgan upgraded Phibro Animal Health Corporation (NASDAQ:PAHC), citing strong execution following its $350 million acquisition of Zoetis' medicated feed additive and water-soluble product portfolio. The deal includes 37 product lines sold in about 80 countries, six manufacturing sites across the...

Johnson & Johnson’s (NYSE:JNJ) Abiomed has issued an Early Alert regarding its Automated Impella Controllers (AIC) for Impella heart pumps, a device crucial for patients with severe heart conditions. This alert, issued by the Food and Drug Administration (FDA), highlights a critical...

BofA Securities analyst Michael J. Funk reinstated coverage with a Buy rating on T-Mobile US Inc (NASDAQ:TMUS) and separate company notes. The telecom industry is often viewed as homogeneous. Still, Funk noted that AT&T (NYSE:T), rated as a Buy with a price target of $32; T-Mobile, rated...

Jasper Therapeutics, Inc. (NASDAQ:JSPR) stock is experiencing a steep decline on Monday, plummeting by nearly 55%. This significant drop is accompanied by an exceptionally high trading volume of 9.9 million shares, vastly exceeding its average daily volume of 251.9K, according to data from Benzinga...

Managed care insurers have faced a turbulent few months, with several major players experiencing steep market capitalization losses amid earnings uncertainty and looming policy shifts. UnitedHealth Leads The Downturn Amidst Guidance Withdrawal And CEO Resignation UnitedHealth Group Inc. (NYSE:UNH)...

BofAmerica Securities analyst Koji Ikeda maintained Datadog Inc (NASDAQ:DDOG) with a Buy and raised the price target from $150 to $175 on Monday. The S&P Dow Jones Indices announced on July 2, 2025, that software vendor Datadog was joining the S&P 500, effective July 9, 2025...

Mullen Automotive (NASDAQ:MULN) stock was trading upwards on Monday. Why? The U.S. House of Representatives passed President Donald Trump’s “Big Beautiful Bill,” which removes the $7,500 tax credit for new U.S.-made EVs. The tax break will end on September 30, prompting some...

Palantir Technologies (NASDAQ:PLTR) stock surged 79% year-to-date, driven by quarterly earnings, a boost in government contract revenue, and positive analyst sentiment. Palantir has far outpaced the market indices. The S&P 500 and the Nasdaq-100 (which also includes Palantir) gained 7-9% during...

Hims & Hers Health, Inc. (NYSE:HIMS) is currently experiencing a decline in its stock price, trading lower on Monday. The company’s stock has plummeted approximately 18% over the past month, reflecting recent challenges. A significant development contributing to this decline occurred in...

Dow Inc. (NYSE:DOW) is moving forward with a series of strategic asset closures across Europe as part of a broader restructuring plan to boost long-term profitability and streamline global operations. The decision, approved by the board, involves winding down operations at an ethylene cracker in...

Royal Gold, Inc. (NASDAQ:RGLD) is making a decisive move to scale up in the precious metals streaming and royalty space through two simultaneous acquisitions, a $3.5 billion all-share merger with Sandstorm Gold Ltd. (NYSE:SAND) and a $196 million cash deal for Horizon Copper Corp. (OTC:HNCUF)....

Shell plc (NYSE:SHEL) on Monday released its updated financial outlook for the second quarter of 2025, ahead of its scheduled July 31 earnings report. The guidance outlines expected performance across major business segments, including gas production, marketing, chemicals, and renewables. Output...

Cogent Biosciences, Inc.‘s (NASDAQ:COGT) bezuclastinib showed meaningful clinical benefit for patients with non-advanced systemic mastocytosis, a rare and debilitating immune disorder. With statistically significant improvements across all endpoints—including symptom reduction and biomarkers...

Molina Healthcare, Inc. (NYSE:MOH) on Monday issued preliminary second-quarter results and lowered its full-year 2025 earnings outlook, citing rising medical costs across its Medicaid, Medicare, and state marketplace businesses. The managed care company now expects Q2 adjusted earnings of...

A fresh controversy is brewing in China’s intensely competitive artificial intelligence market as Huawei Technologies’ AI research arm has firmly rejected allegations of plagiarizing elements from an Alibaba Group Holding (NYSE:BABA) model. This denial comes as Alibaba’s stock...